P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.895 MYR -2.72% Market Closed
Market Cap: 1.2B MYR

Wall St Price Targets

PHARMA Price Forecast
Based on 4 analysts

+128% Upside
from 0.895 MYR today

Pharmaniaga Bhd (PHARMA)’s 12-month stock price forecast through October 2027 has a consensus target of 2.04 MYR, implying 128% upside. The forecast is based on price targets from 4 Wall Street analysts.

PHARMA Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for PHARMA yet.

Pharmaniaga Bhd Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PHARMA's stock price target?
Price Target
2.04 MYR

According to Wall Street analysts, the average 1-year price target for PHARMA is 2.04 MYR with a low forecast of 1.162 MYR and a high forecast of 7.56 MYR.

What is the Revenue forecast for Pharmaniaga Bhd?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 5%.

What is the Gross Profit forecast for Pharmaniaga Bhd?
Projected CAGR
-2%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next -3 years is -2%.

What is the Operating Income forecast for Pharmaniaga Bhd?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 24%.

What is the Pre-Tax Income forecast for Pharmaniaga Bhd?
Projected CAGR
39%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 3 years is 39%.

What is the Net Income forecast for Pharmaniaga Bhd?
Projected CAGR
46%

Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 3 years is 46%.

Back to Top